Prevalence of Metallo-β-lactamases in Imipenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii
暂无分享,去创建一个
J. Ha | N. Ryoo | D. Jeon | Jae Ryong Kim
[1] Je Chul Lee,et al. Dissemination of the blaIMP-1 and blaVIM-2 metallo-beta-lactamase genes among genetically unrelated Pseudomonas aeruginosa isolates in a South Korean hospital. , 2008, International journal of antimicrobial agents.
[2] K. Bush,et al. Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.
[3] R. Koncan,et al. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. , 2007, International journal of antimicrobial agents.
[4] Chang Ki Kim,et al. Antimicrobial Resistance of Clinically Important Bacteria Isolated from 12 Hospitals in Korea in 2005 and 2006 , 2007 .
[5] N. Høiby,et al. OXA-type carbapenemases. , 2006, The Journal of antimicrobial chemotherapy.
[6] C. Ki,et al. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-beta-lactamase producers in a Korean hospital. , 2005, Microbial drug resistance.
[7] R. Bonomo,et al. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! , 2005, Current opinion in microbiology.
[8] Seungok Lee,et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. , 2005, The Journal of antimicrobial chemotherapy.
[9] A. Bolmström,et al. Evaluation of Etest MBL for Detection of blaIMP-1 and blaVIM-2 Allele-Positive Clinical Isolates of Pseudomonas spp. and Acinetobacter spp , 2005, Journal of Clinical Microbiology.
[10] D. Yong,et al. Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp. , 2004, Diagnostic microbiology and infectious disease.
[11] D. Yong,et al. Antimicrobial Resistance of Clinically Important Bacteria Isolated from 12 Hospitals in Korea in 2004 , 2004 .
[12] Seungok Lee,et al. Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean University hospital and comparison of screening methods for detecting metallo-β-lactamase , 2003 .
[13] P. Nordmann,et al. Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] D. Livermore,et al. bla VIM-2 Cassette-Containing Novel Integrons in Metallo-β-Lactamase-Producing Pseudomonas aeruginosa and Pseudomonas putida Isolates Disseminated in a Korean Hospital , 2002, Antimicrobial Agents and Chemotherapy.
[15] Thierry Naas,et al. Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France , 2000, Antimicrobial Agents and Chemotherapy.
[16] G. Jacoby,et al. More extended-spectrum beta-lactamases , 1991, Antimicrobial Agents and Chemotherapy.
[17] S. Jeong,et al. Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital. , 2009, Diagnostic microbiology and infectious disease.
[18] L. By,et al. Prevalence of Imipenem-Resistant Pseudomonas aeruginosa Isolates and Mechanisms of Resistance. , 2005 .
[19] Seungok Lee,et al. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase. , 2003, Journal of microbiological methods.